文献速递神经肿瘤

胶质母细胞瘤早期浸润阶段假说:分子型胶质母细胞瘤是组织学胶质母细胞瘤的前身吗?一项初步多中心研究

The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study.
PubMed 文献 · J Neurooncol · 2022-06-14

该研究回顾性分析2017年11月至2021年10月三家三级医疗中心65例分子型胶质母细胞瘤患者,最终纳入5例复发再手术且初诊与复发组织可用的患者。初诊时均无微血管增生和假栅栏状坏死,复发时4例(80%)出现;影像学初诊均无典型胶质母细胞瘤特征但均有强化。作者提出分子型胶质母细胞瘤是早期组织学胶质母细胞瘤的假说,需进一步相关研究支持。

要点

  • 5例分子型胶质母细胞瘤患者初诊无坏死和微血管增生,复发时4例(80%)出现。
  • 初诊影像均无典型胶质母细胞瘤特征,但全部显示对比强化。
  • 3例(60%)原发部位复发再手术,2例(40%)远处复发再手术。

核心结论

  • 作者提出分子型胶质母细胞瘤是疾病自然史早期诊断的组织学胶质母细胞瘤,最终将发展为坏死和微血管增生,需进一步相关研究支持该假说。

研究设计与样本

  • 回顾性研究,从2017年11月至2021年10月三家三级医疗中心连续65例分子型胶质母细胞瘤患者中,纳入复发再手术且初诊与复发组织可用的5例患者。

主要发现

  • 最终队列5例,3例(60%)原发部位复发再手术,2例(40%)远处复发再手术。
  • 初诊时无微血管增生和假栅栏状坏死,复发时4例(80%)出现。
  • 影像学上所有肿瘤均显示对比强化,但初诊时均无典型胶质母细胞瘤影像学特征。

局限性

  • 原文未报告局限性,但结论指出需进一步相关研究支持该假说。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The presence of necrosis or microvascular proliferation was previously the hallmark for glioblastoma (GBM) diagnosis. The 2021 WHO classification now considers IDH-wildtype diffuse astrocytic tumors without the histological features of glioblastoma (that would have otherwise been classified as grade 2 or 3) as molecular GBM (molGBM) if they harbor any of the following molecular abnormalities: TERT promoter mutation, EGFR amplification, or chromosomal + 7/-10 copy changes. We hypothesize that these tumors are early histological GBM and will eventually develop the classic histological features. METHODS: Medical records from 65 consecutive patients diagnosed with molGBM at three tertiary-care centers from our institution were retrospectively reviewed from November 2017-October 2021. Only patients who underwent reoperation for tumor recurrence and whose tissue at initial diagnosis and recurrence was available were included in this study. The detailed clinical, histopathological, and radiographic scenarios are presented. RESULTS: Five patients were included in our final cohort. Three (60%) patients underwent reoperation for recurrence in the primary site and 2 (40%) underwent reoperation for distal recurrence. Microvascular proliferation and pseudopalisading necrosis were absent at initial diagnosis but present at recurrence in 4 (80%) patients. Radiographically, all tumors showed contrast enhancement, however none of them showed the classic radiographic features of GBM at initial diagnosis. CONCLUSIONS: In this manuscript we present preliminary data for a hypothesis that molGBMs are early histological GBMs diagnosed early in their natural history of disease and will eventually develop necrosis and microvascular proliferation. Further correlative studies are needed in support of this hypothesis.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Ramos-Fresnedo A, Domingo RA, Perez-Vega C, et al. The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study. J Neurooncol. 2022. PMID: 35699848. doi:10.1007/s11060-022-04040-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。